Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

In recent years, the use of immune checkpoint inhibitors (ICIs) in combination with approved
or experimental vaccines has proven to be a promising approach to improve vaccine …

Complex pathological diseases, such as cancer, infection, and Alzheimer's, need to be
targeted by multipronged curative. Various omics technologies, with a high rate of data …

Adjuvants play a critical role in enhancing vaccine efficacy; however, there is a need to
develop new immunomodulatory compounds to address emerging pathogens and to …

Recently, there has been increased interest in using mannan as an immunomodulatory
bioconjugate. Despite notable immunological and functional differences between the …

Adjuvants represent one of the most significant biotechnological solutions regarding vaccine
development, thereby broadening the amount of candidates which can now be used and …

Background Adjuvants are chemical or biological materials that enhance the efficacy of
vaccines. A-910823 is a squalene-based emulsion adjuvant used for S-268019-b, a novel …

Pattern recognition receptors (PRRs) recognize distinct features on the surface of pathogens
or damaged cells and play key roles in the innate immune system. PRRs are divided into …

Field-effect transistors (FETs) have gained significant interest and hold great potential as
groundbreaking sensing technology in the fields of biosensing and life science research …

Vaccines are a powerful medical intervention for preventing epidemic diseases. Efficient
inactivated or protein vaccines typically rely on an effective adjuvant to elicit an immune …